Exclusive

Publication

Byline

Location

US Patent Issued to Xyra on Oct. 27 for "Formulations of crystalline budiodarone Form-1" (California Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,398, issued on Oct. 27, was assigned to Xyra LLC (Los Altos, Calif.). "Formulations of crystalline budiodarone Form-1" was invented by Pasc... Read More


US Patent Issued to SEOUL NATIONAL UNIVERSITY HOSPITAL, KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY on Oct. 27 for "Composition for prevention or treatment of cardiovascular and metabolic disease comprising noranhydroicaritin" (South Korean Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,399, issued on Oct. 27, was assigned to SEOUL NATIONAL UNIVERSITY HOSPITAL (Seoul, South Korea) and KOREA RESEARCH INSTITUTE OF BIOSCIENCE A... Read More


US Patent Issued to The General Hospital on Oct. 27 for "Macrophages/microglia in neuro-inflammation associated with neurodegenerative diseases" (Massachusetts Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,400, issued on Oct. 27, was assigned to The General Hospital Corp. (Boston). "Macrophages/microglia in neuro-inflammation associated with n... Read More


US Patent Issued to Eiger Group International on Oct. 27 for "Use of chloroquine compounds for treatment of inflammatory conditions" (California Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,402, issued on Oct. 27, was assigned to Eiger Group International Inc. (Palo Alto, Calif.). "Use of chloroquine compounds for treatment of ... Read More


US Patent Issued to NOBELPHARMA, YUTOKU PHARMACEUTICAL INDUSTRIES on Oct. 27 for "Scopolamine compositions and transdermal patches made therefrom" (Japanese Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,403, issued on Oct. 27, was assigned to NOBELPHARMA Co. LTD. (Tokyo) and YUTOKU PHARMACEUTICAL INDUSTRIES Co. LTD. (Kashima, Japan). "Scopo... Read More


US Patent Issued to NEURODAWN PHARMACEUTICAL on Oct. 27 for "Use of a class of 1,4-dihydro-naphthyridine derivatives in treatment of tumors" (Chinese Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,404, issued on Oct. 27, was assigned to NEURODAWN PHARMACEUTICAL Co. LTD. (Nanjing, China). "Use of a class of 1,4-dihydro-naphthyridine de... Read More


US Patent Issued to PHARMA MAR on Oct. 27 for "Combination of lurbinectedin and immune checkpoint inhibitors" (French Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,405, issued on Oct. 27, was assigned to PHARMA MAR S.A. (Madrid). "Combination of lurbinectedin and immune checkpoint inhibitors" was inven... Read More


US Patent Issued to Dong-A St on Oct. 27 for "Pharmaceutical composition for prevention or treatment of nonalcoholic steatohepatitis" (South Korean Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,406, issued on Oct. 27, was assigned to Dong-A St Co. Ltd. (South Korea). "Pharmaceutical composition for prevention or treatment of nonalc... Read More


US Patent Issued to Emory University, Clemson University Research Foundation on Oct. 27 for "Methods of managing cocaine or other drug addictions" (Georgia, South Carolina Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,407, issued on Oct. 27, was assigned to Emory University (Atlanta) and Clemson University Research Foundation (Clemson, S.C.). "Methods of ... Read More


US Patent Issued to Bengt Fagrell on Oct. 27 for "Anti-ischemic compositions" (Swedish, American Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,408, issued on Oct. 27, was assigned to Bengt Fagrell (Taby, Sweden). "Anti-ischemic compositions" was invented by Bengt Fagrell (Taby, Swe... Read More